Lisdexamfetamine dimesylate is the active ingredient of the pharmaceutical drug Vyvanse. It is frequently used to treat attention deficit hyperactivity disorder (ADHD) in children, adolescents, and adults. The medicine Vyvanse is categorized as a central nervous system (CNS) stimulant.
As a prodrug, lisdexamfetamine is inactive until the body metabolizes it. Once consumed, it is transformed into dextroamphetamine, a stimulant that alters brain and nerve chemicals associated with hyperactivity and impulse control.
